Michael R. Megna - Jan 15, 2023 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Madlyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Jan 15, 2023
Transactions value $
-$2,864
Form type
4
Date filed
3/20/2023, 05:18 PM
Previous filing
Oct 6, 2022
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Common Share Award $6.73K +704 +9.5% $9.56 8.12K Jan 15, 2023 Direct F1
transaction KNSA Class A Common Share Options Exercise +774 +9.53% 8.89K Mar 16, 2023 Direct F2
transaction KNSA Class A Common Share Tax liability -$2.53K -221 -2.49% $11.46 8.67K Mar 16, 2023 Direct
transaction KNSA Class A Common Share Options Exercise +2.16K +24.95% 10.8K Mar 20, 2023 Direct F2
transaction KNSA Class A Common Share Tax liability -$7.06K -635 -5.86% $11.12 10.2K Mar 20, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Options Exercise $0 -774 -33.32% $0.00 1.55K Mar 16, 2023 Class A Common Share 774 Direct F2, F3
transaction KNSA Restricted Share Unit Options Exercise $0 -2.16K -100% $0.00* 0 Mar 20, 2023 Class A Common Share 2.16K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2022 to January 15, 2023. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).
F2 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F3 The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, March 16, 2021.
F4 The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2023; there was no expiration date for the RSUs.